The University of Southampton
University of Southampton Institutional Repository

Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry

Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry
Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry
Introduction: sarcoidosis varies by ethnicity, affecting presentation, comorbidities, and outcomes.

Objectives: we aimed to identify ethnic disparities in the presentation and management of UK Sarcoidosis patients.

Methods: we analyzed BTS UK ILD registry data (2013–2024), comparing demographics, symptoms, comorbidities, pulmonary function, and outcomes by ethnicity. All patients provided informed consent. Statistical analysis was performed.

Results: 736 sarcoidosis patients were included (19% NonWhite - 7% Black African/Caribbean; 8% South Asian, Indian, Pakistani, Bangladeshi (SA); 2% Mixed Ethnicity). NonWhites were younger (52 [42-61] vs 54 [44-62], p<0.001), less often current/ex-smokers (7 vs 30%, p=0.05), and had more comorbidities (40 vs 31%, p=0.029), including TB (7 vs 2%, p<0.001) and diabetes (21 vs 13%, p=0.014). Ischemic heart disease was more frequent in SA (11 vs 7%, p=0.019). NonWhites had more erythema nodosum (10 vs 5%, p=0.027) and fever (3 vs 1%, p=0.044). Despite more prevalent breathlessness in Whites (26 vs 19%, p=0.008), NonWhites had lower baseline FVC and DLCO% (94 [82-107] vs 97% [83-110], p=0.038; 78 [65-90] vs 80% [70-93], p=0.019). Whites had more lymphopenia (32 vs 17%, p=0.002), while Blacks more often had abnormal liver function (21 vs 16%, p=0.013). Pharmacotherapies were similar, but Whites had higher referrals for pulmonary rehab (47 vs 33%, p=0.002) and MDT discussion (57% vs 18%, p=0.032). NonWhites were often from deprived areas (37 vs 24%; IMDQ1&2, p=0.022)

Conclusions: distinct ethnic differences exist in many factors warranting deeper investigation for long-term implications
0903-1936
Bączek, Karol
4329175e-6e07-4c48-9676-637ba0ec5af2
Minnis, Paul
d1de4943-e2c9-4bfe-958b-431d284dbf1c
Bloye, Graham
e16a131d-53e2-4a6c-9e84-3f078c3ce016
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe
et al.
Bączek, Karol
4329175e-6e07-4c48-9676-637ba0ec5af2
Minnis, Paul
d1de4943-e2c9-4bfe-958b-431d284dbf1c
Bloye, Graham
e16a131d-53e2-4a6c-9e84-3f078c3ce016
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe

et al. (2025) Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry. European Respiratory Journal, 66. (doi:10.1183/13993003.congress-2025.OA5503).

Record type: Meeting abstract

Abstract

Introduction: sarcoidosis varies by ethnicity, affecting presentation, comorbidities, and outcomes.

Objectives: we aimed to identify ethnic disparities in the presentation and management of UK Sarcoidosis patients.

Methods: we analyzed BTS UK ILD registry data (2013–2024), comparing demographics, symptoms, comorbidities, pulmonary function, and outcomes by ethnicity. All patients provided informed consent. Statistical analysis was performed.

Results: 736 sarcoidosis patients were included (19% NonWhite - 7% Black African/Caribbean; 8% South Asian, Indian, Pakistani, Bangladeshi (SA); 2% Mixed Ethnicity). NonWhites were younger (52 [42-61] vs 54 [44-62], p<0.001), less often current/ex-smokers (7 vs 30%, p=0.05), and had more comorbidities (40 vs 31%, p=0.029), including TB (7 vs 2%, p<0.001) and diabetes (21 vs 13%, p=0.014). Ischemic heart disease was more frequent in SA (11 vs 7%, p=0.019). NonWhites had more erythema nodosum (10 vs 5%, p=0.027) and fever (3 vs 1%, p=0.044). Despite more prevalent breathlessness in Whites (26 vs 19%, p=0.008), NonWhites had lower baseline FVC and DLCO% (94 [82-107] vs 97% [83-110], p=0.038; 78 [65-90] vs 80% [70-93], p=0.019). Whites had more lymphopenia (32 vs 17%, p=0.002), while Blacks more often had abnormal liver function (21 vs 16%, p=0.013). Pharmacotherapies were similar, but Whites had higher referrals for pulmonary rehab (47 vs 33%, p=0.002) and MDT discussion (57% vs 18%, p=0.032). NonWhites were often from deprived areas (37 vs 24%; IMDQ1&2, p=0.022)

Conclusions: distinct ethnic differences exist in many factors warranting deeper investigation for long-term implications

This record has no associated files available for download.

More information

e-pub ahead of print date: 18 November 2025

Identifiers

Local EPrints ID: 510814
URI: http://eprints.soton.ac.uk/id/eprint/510814
ISSN: 0903-1936
PURE UUID: 0d8ad57b-0681-421c-9896-5f3ed1eb571d
ORCID for Sophie Fletcher: ORCID iD orcid.org/0000-0002-5633-905X

Catalogue record

Date deposited: 22 Apr 2026 16:47
Last modified: 25 Apr 2026 03:55

Export record

Altmetrics

Contributors

Author: Karol Bączek
Author: Paul Minnis
Author: Graham Bloye
Author: Sophie Fletcher ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×